{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:50Z","timestamp":1760188850251,"version":"build-2065373602"},"reference-count":155,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.soncn.2006.11.006","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T07:08:10Z","timestamp":1171436890000},"page":"55-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endocrine Effects of Breast Cancer Treatment"],"prefix":"10.1016","volume":"23","author":[{"given":"Carrie Tompkins","family":"Stricker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2006","series-title":"From Cancer Patient to Cancer Survivor: Lost in Transition","author":"Hewitt","key":"10.1016\/j.soncn.2006.11.006_bib1"},{"key":"10.1016\/j.soncn.2006.11.006_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BD-2004-21108","article-title":"Long-term complications of adjuvant chemotherapy for early stage breast cancer","volume":"21","author":"Partridge","year":"2004","journal-title":"Breast Disease"},{"issue":"suppl 11","key":"10.1016\/j.soncn.2006.11.006_bib3","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.21250","article-title":"A model for care across the cancer continuum","volume":"104","author":"Hudson","year":"2005","journal-title":"Cancer"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib4","first-page":"S1","article-title":"NCCN Task Force Report: adjuvant therapy for breast cancer","volume":"4","author":"Carlson","year":"2006","journal-title":"J Natl Comp Cancer Ntwk"},{"key":"10.1016\/j.soncn.2006.11.006_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0015-0282(97)80073-8","article-title":"Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue","volume":"67","author":"Oktay","year":"1997","journal-title":"Fertility Sterility"},{"key":"10.1016\/j.soncn.2006.11.006_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra043475","article-title":"Potential options for preservation of fertility in women","volume":"353","author":"Lobo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib7","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","article-title":"The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors","volume":"11","author":"Knobf","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.soncn.2006.11.006_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1200\/jco.2005.23.16_suppl.687","article-title":"Delayed premature menopause following chemotherapy for early stage breast cancer: long-term results from IBCSG trial V","volume":"23","author":"Partridge","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib10","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.annonc.a057718","article-title":"The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients","volume":"1","author":"Goldhirsch","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","article-title":"Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study","volume":"24","author":"Petrek","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","article-title":"Fertility preservation in young women undergoing breast cancer therapy","volume":"11","author":"Sonmezer","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.soncn.2006.11.006_bib14","first-page":"320","article-title":"Adjuvant therapy for breast cancer: no pain, no gain?","volume":"16","author":"Ganz","year":"2006","journal-title":"Breast Diseases: A Year Book Quarterly"},{"key":"10.1016\/j.soncn.2006.11.006_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.critrevonc.2005.04.009","article-title":"Hot flushes in breast cancer patients","volume":"57","author":"Mom","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.soncn.2006.11.006_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13697130500487224","article-title":"Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life","volume":"9","author":"Gupta","year":"2006","journal-title":"Climacteric"},{"key":"10.1016\/j.soncn.2006.11.006_bib17","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0","article-title":"Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life","volume":"82","author":"Carpenter","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib18","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1188\/02.ONF.E16-E25","article-title":"Hot flashes and related outcomes in breast cancer survivors and matched comparison women","volume":"29","author":"Carpenter","year":"2002","journal-title":"Oncol Nurs Forum Online"},{"key":"10.1016\/j.soncn.2006.11.006_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/sonc.2000.8116","article-title":"Hot flashes and their management in breast cancer","volume":"16","author":"Carpenter","year":"2000","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.soncn.2006.11.006_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1188\/03.ONF.393-407","article-title":"Comprehensive menopausal assessment: an approach to managing vasomotor and urogenital symptoms in breast cancer survivors","volume":"30","author":"Zibecchi","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2006.11.006_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0531-5565(94)90012-4","article-title":"Hot flashes: phenomenology, quality of life, and search for treatment options","volume":"29","author":"Kronenberg","year":"1994","journal-title":"Exp Gerontol"},{"issue":"suppl 2","key":"10.1016\/j.soncn.2006.11.006_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2005.09.046","article-title":"Hot flashes: behavioral treatments, mechanisms, and relation to sleep","volume":"118","author":"Freedman","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib23","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1995.13.11.2737","article-title":"Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy","volume":"13","author":"Couzi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1010684903199","article-title":"Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for \u2018well-tolerated\u2019 treatments?","volume":"66","author":"Fellowes","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2006.11.006_bib25","first-page":"42","article-title":"Menopause and breast cancer","volume":"2","author":"Ganz","year":"1997","journal-title":"Innov Breast Cancer Care"},{"key":"10.1016\/j.soncn.2006.11.006_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","article-title":"Life after breast cancer: understanding women\u2019s health related quality of life and sexual functioning","volume":"16","author":"Ganz","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00002820-199608000-00007","article-title":"Sexual functioning in women with breast cancer after treatment with adjuvant therapy","volume":"19","author":"Young-McCaughan","year":"1996","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.soncn.2006.11.006_bib28","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","article-title":"Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women","volume":"23","author":"Whelan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib30","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/02841860050215945","article-title":"Randomized trial of adjuvant tamoxifen and\/or goserelin in premenopausal breast cancer-self rated physiological effects and symptoms","volume":"39","author":"Nystedt","year":"2000","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.soncn.2006.11.006_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1470-2045(05)70316-8","article-title":"Management of menopausal symptoms in patients with breast cancer: an evidence-based approach","volume":"6","author":"Hickey","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (Hormone Replacement Therapy after Breast Cancer - is it safe?), a randomized comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2006.11.006_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.maturitas.2005.03.004","article-title":"Menopausal hormone therapy (HT) in patients with breast cancer","volume":"53","author":"Batur","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.soncn.2006.11.006_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","article-title":"Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes","volume":"82","author":"Quella","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0885-3924(02)00525-0","article-title":"Depomedroxyprogesterone acetate for hot flashes","volume":"24","author":"Barton","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.soncn.2006.11.006_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of post-menopausal hot flashes in breast cancer patients: a randomized study","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Dose-response analysis of effects of tibolone on climacteric symptoms","volume":"109","author":"Landgren","year":"2002","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2005.01.001","article-title":"Evaluation of low-does venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors","volume":"52","author":"Biglia","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.soncn.2006.11.006_bib42","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2006.11.006_bib43","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2006.11.006_bib44","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1075-122X.2006.00218.x","article-title":"Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen","volume":"12","author":"Kimmick","year":"2006","journal-title":"Breast J"},{"key":"10.1016\/j.soncn.2006.11.006_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.soncn.2006.11.006_bib48","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/djg108","article-title":"Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine","volume":"95","author":"Stearns","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soncn.2006.11.006_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","article-title":"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment","volume":"97","author":"Jin","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 2","key":"10.1016\/j.soncn.2006.11.006_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjmed.2005.09.045","article-title":"Centrally active nonhormonal hot flash therapies","volume":"118","author":"Loprinzi","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2006.11.006_bib52","first-page":"337","article-title":"Gabapentin\u2019s effects on hot flashes in postmenopausal women: a randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib53","first-page":"583","article-title":"Effect of clonidine on hot flashes in postmenopausal women","volume":"60","author":"Laufer","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9378(87)90050-0","article-title":"Treatment of menopausal hot flashes with transdermal administration of clonidine","volume":"156","author":"Nagamani","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib55","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in post-menopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.GME.0000113932.56832.27","article-title":"Effects of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women","volume":"11","author":"Aiello","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.soncn.2006.11.006_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2114\/jpa.23.143","article-title":"A 12-week structured education and exercise program improved climacteric symptoms in middle-aged women","volume":"23","author":"Ueda","year":"2004","journal-title":"J Physiol Anthropol Appl Human Sci"},{"key":"10.1016\/j.soncn.2006.11.006_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(03)00187-7","article-title":"Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomized to physical activity or estrogen therapy","volume":"48","author":"Lindh-Astrand","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.soncn.2006.11.006_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00002820-200204000-00005","article-title":"A pilot study of magnetic therapy for hot flashes after breast cancer","volume":"25","author":"Carpenter","year":"2002","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.soncn.2006.11.006_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/acm.2005.11.21","article-title":"Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial","volume":"11","author":"Jacobs","year":"2005","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib62","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13697130500117987","article-title":"Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study","volume":"8","author":"Winther","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.soncn.2006.11.006_bib63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9378(11)91425-2","article-title":"Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring","volume":"167","author":"Freedman","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib64","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1037\/0022-006X.52.6.1072","article-title":"Behavioral treatment of menopausal hot flashes: evaluation by ambulatory monitoring","volume":"52","author":"Germaine","year":"1984","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.soncn.2006.11.006_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/01674829609025684","article-title":"The effects of relaxation response training on menopausal symptoms","volume":"17","author":"Irvin","year":"1996","journal-title":"J Psychosom Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13697130410001713814","article-title":"A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women","volume":"7","author":"Wyon","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.soncn.2006.11.006_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13697130500118050","article-title":"Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study","volume":"8","author":"Nedstrand","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.soncn.2006.11.006_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/aim.23.4.171","article-title":"Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients\u2013audit and treatment algorithm","volume":"23","author":"Filshie","year":"2005","journal-title":"Acupunct Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib69","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.AOG.0000140688.71638.d3","article-title":"Phytoestrogens for treatment of menopausal symptoms: a systematic review","volume":"104","author":"Krebs","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib70","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO.2001.19.10.2739","article-title":"Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer","volume":"19","author":"Jacobson","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1081\/CNV-200026394","article-title":"Pilot evaluation of black cohosh for the treatment of hot flashes in women","volume":"22","author":"Pockaj","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1016\/j.soncn.2006.11.006_bib72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/j.1326-5377.2003.tb05606.x","article-title":"Acute liver failure associated with the use of herbal preparations containing black cohosh","volume":"179","author":"Lontos","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.soncn.2006.11.006_bib73","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10484-005-2171-1","article-title":"A behavioral group treatment program for menopausal hot flashes: results of a pilot study","volume":"30","author":"Keefer","year":"2005","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"10.1016\/j.soncn.2006.11.006_bib75","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1200\/JCO.2005.04.7159","article-title":"Randomized trial of peer counseling on reproductive health in African American breast cancer survivors","volume":"24","author":"Schover","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib76","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soncn.2006.11.006_bib77","first-page":"222","article-title":"SOCG Clinical Practice Guidelines","volume":"88","year":"2005","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.soncn.2006.11.006_bib78","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.maturitas.2005.06.014","article-title":"Management of post-menopausal vaginal atrophy and atrophic vaginitis","volume":"52S","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.soncn.2006.11.006_bib79","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis","volume":"61","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.soncn.2006.11.006_bib80","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bjc.1991.131","article-title":"Primary systemic therapy for operable breast cancer","volume":"63","author":"Anderson","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib81","first-page":"597","article-title":"Cigarette smoking and vaginal atrophy in postmenopausal women","volume":"10","author":"Kalogeraki","year":"1996","journal-title":"In Vivo"},{"key":"10.1016\/j.soncn.2006.11.006_bib82","first-page":"722","article-title":"Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus vaginal cream for urogenital atrophy","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.soncn.2006.11.006_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib85","first-page":"6044","article-title":"Vaginal estrogens appear to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"94","author":"Kendall","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl","key":"10.1016\/j.soncn.2006.11.006_bib86","first-page":"16","article-title":"Estrogens - pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation - Estring","volume":"163","author":"Johnston","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.soncn.2006.11.006_bib87","first-page":"215","article-title":"Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium","volume":"84","author":"Handa","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year mulitcenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.soncn.2006.11.006_bib89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.soncn.2006.11.006_bib90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: replens vs. local estrogen in menopausal women","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.soncn.2006.11.006_bib91","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-based survey of fertility issues in young women with breast cancer","volume":"22","author":"Partridge","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib92","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology Recommendations for Fertility Preservation in Cancer Patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib93","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.2002.07.175","article-title":"Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors","volume":"20","author":"Schover","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib94","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1464-410X.1989.tb05292.x","article-title":"Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?","volume":"64","author":"Fossa","year":"1989","journal-title":"Br J Urol"},{"key":"10.1016\/j.soncn.2006.11.006_bib95","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J","article-title":"Having children after cancer: a pilot survey of survivors\u2019 attitudes and experiences","volume":"86","author":"Schover","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib96","first-page":"693","article-title":"Pregnancy and breast cancer: epidemiology, treatment, and safety issues","volume":"19","author":"Partridge","year":"2005","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.soncn.2006.11.006_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3816\/CBC.2005.n.040","article-title":"Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy","volume":"6","author":"Fanale","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1200\/JCO.2005.04.6607","article-title":"Effect of adjuvant trastuzumab on pregnancy","volume":"24","author":"Waterston","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib99","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.breast.2004.08.007","article-title":"Tamoxifen and pregnancy","volume":"13","author":"Barthelmes","year":"2004","journal-title":"Breast"},{"key":"10.1016\/j.soncn.2006.11.006_bib100","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2005.04.011","article-title":"Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib101","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib102","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen","volume":"18","author":"Oktay","year":"2003","journal-title":"Hum Reprod"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib103","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.ejogrb.2003.11.010","article-title":"Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer","volume":"113","author":"Oktay","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.soncn.2006.11.006_bib104","first-page":"528","article-title":"Preventing chemotherapy-associated amenorrhea (CRA) with leuprolide during adjuvant chemotherapy for early-stage breast cancer","volume":"22","author":"Fox","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cncr.21646","article-title":"Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma","volume":"106","author":"Recchia","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib106","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1470-2045(05)70185-6","article-title":"UK clinicians to screen embryos for BRCA mutations","volume":"6","author":"Tilstone","year":"2005","journal-title":"Lancet Oncol"},{"issue":"suppl 2","key":"10.1016\/j.soncn.2006.11.006_bib107","first-page":"S-1","article-title":"NCCN Task Force Report: Bone Health and Cancer Care","volume":"4","author":"Theriault","year":"2006","journal-title":"J Natl Compr Cancer Ntwk"},{"key":"10.1016\/j.soncn.2006.11.006_bib108","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1200\/JCO.2003.04.596","article-title":"American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting","volume":"21","author":"Winer","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib109","unstructured":"World Health Organization (WHO). Prevention and Management of Osteoporosis: Report of a WHO Scientific Group. WHO Technical Report Series. Available at: http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_921.pdf. (accessed April 24, 2006)."},{"key":"10.1016\/j.soncn.2006.11.006_bib110","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","article-title":"Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies","volume":"16","author":"Boonen","year":"2005","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.soncn.2006.11.006_bib111","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: scientific review","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2006.11.006_bib112","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib113","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa022464","article-title":"Bone loss and bone size after menopause","volume":"349","author":"Ahlborg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib114","series-title":"Harrison\u2019s Internal Medicine","first-page":"2238","article-title":"Bone and mineral metabolism in health and disease","author":"Bringhurst","year":"2005"},{"key":"10.1016\/j.soncn.2006.11.006_bib115","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib116","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","article-title":"Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients","volume":"15","author":"Saarto","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib117","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjc.1990.58","article-title":"Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer","volume":"61","author":"Bruning","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/B:BREA.0000041624.00665.4e","article-title":"Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure","volume":"87","author":"Vehmanen","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2006.11.006_bib120","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib121","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","article-title":"Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients","volume":"15","author":"Saarto","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib122","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jbmr.5650100505","article-title":"Cyclic clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy","volume":"10","author":"Filipponi","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.soncn.2006.11.006_bib123","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-97-5-699","article-title":"Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy","volume":"97","author":"Genant","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib124","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","article-title":"Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients","volume":"37","author":"Vehmanen","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib125","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/bjc.1997.105","article-title":"Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens","volume":"75","author":"Saarto","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2005.04.009","article-title":"Long-term effects of aromatase inhibitors on bone","volume":"95","author":"Eastell","year":"2005","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1016\/j.soncn.2006.11.006_bib127","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","article-title":"Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy","volume":"22","author":"Sverrisdottir","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib129","first-page":"S8","volume":"88","author":"Gnant","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2006.11.006_bib130","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib131","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib132","first-page":"S27","article-title":"Effect of anastrozole on bone mineral density: 2-year results of the \u2018Arimidex\u2019 (anastrazole), tamoxifen, alone or in combination (ATAC) trial","volume":"82","author":"Howell","year":"2003","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib133","first-page":"S35","article-title":"Intergroup Exemestane Study: 1 year results of the bone subprotocol","volume":"88","author":"Coleman","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2006.11.006_bib134","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer","volume":"23","author":"Lonning","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.soncn.2006.11.006_bib135","first-page":"S36","article-title":"Effect of letrozole versus placebo on bone mineral density in women completing >5 years of adjuvant tamoxifen: NCIC CTG MA-17B","volume":"88","author":"Perez","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2006.11.006_bib136","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1200\/jco.2006.24.18_suppl.511","article-title":"Effect of anastrazole on bone mineral density: 5-year results from the \u2019Armidex\u2019, Tamoxifen, Alone or in Combination (ATAC) trial","volume":"24","author":"Coleman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib137","unstructured":"National Osteoporosis Foundation. NOF Physician\u2019s Guidelines. September 2005. Pharmacologic Options. Available at: http:\/\/www.nof.org\/professionals\/clinical.htm. (accessed April 20, 2006)."},{"key":"10.1016\/j.soncn.2006.11.006_bib138","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-137-6-200209170-00014","article-title":"Screening for osteoporosis in postmenopausal women: recommendations and rationale","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib139","series-title":"Harrison\u2019s Internal Medicine","first-page":"2268","article-title":"Osteoporosis","author":"Lindsay","year":"2005"},{"key":"10.1016\/j.soncn.2006.11.006_bib140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cncr.21201","article-title":"Clinical management of osteoporosis in women with a history of breast carcinoma","volume":"104","author":"Van Poznak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.11.006_bib141","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.soncn.2006.11.006_bib142","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.soncn.2006.11.006_bib143","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib144","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMe068007","article-title":"Calcium plus vitamin D for postmenopausal women\u2013bone appetit?","volume":"354","author":"Finkelstein","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/er.2001-7002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Shea","year":"2002","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.soncn.2006.11.006_bib146","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/jco.2005.23.16_suppl.533","article-title":"Zoledronic acid effectively inhibits cancer treatment-induced bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 12-month BMD results of the Z-FAST trial","volume":"23","author":"Brufsky","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib147","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1200\/jco.2005.23.16_suppl.8023","article-title":"Can an annual infusion of zoledronic acid protect against cancer-treatment induced bone loss?","volume":"23","author":"Brown","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib148","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib149","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","article-title":"Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates","volume":"116","author":"Farrugia","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soncn.2006.11.006_bib150","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.soncn.2006.11.006_bib151","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/er.2001-4002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.soncn.2006.11.006_bib152","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer","volume":"30","author":"Ramaswamy","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.soncn.2006.11.006_bib153","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.soncn.2006.11.006_bib154","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2006.11.006_bib155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208106001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208106001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:36:57Z","timestamp":1760071017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208106001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0749208106001598"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2006.11.006","relation":{},"ISSN":["0749-2081"],"issn-type":[{"type":"print","value":"0749-2081"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Effects of Breast Cancer Treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2006.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}